Document is current

Any future updates will be listed below

Correction to: Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences

Crossref DOI link: https://doi.org/10.1007/s12325-021-01901-9

Published Online: 2021-09-03

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark